{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-028615","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2026-06-15T12:01:16+00:00","discovered_at":"2026-06-15T12:05:16.426500+00:00","generated_at":"2026-06-15T12:06:48.125518+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"AIM ImmunoTech regains NYSE American listing compliance after equity deficiency resolved","bullets":["Received NYSE American notice on June 12, 2026 that it resolved stockholders' equity deficiencies under Sections 1003(a)(i)-(iii).","Raised ~$8.5M total through warrant exercises and stock sales: $3.5M (May 7 warrant inducement), $2.4M (May 21 placement), $2.6M (June 10 placement).","Issued over 10M shares and warrants; believes stockholders' equity now exceeds $6M minimum requirement.","\".BC\" indicator to be removed from trading symbol (AIM); company removed from NYSE American noncompliant list."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-028615","json":"https://secwatch.observer/filing/0001493152-26-028615.json","markdown":"https://secwatch.observer/filing/0001493152-26-028615.md","text":"https://secwatch.observer/filing/0001493152-26-028615.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315226028615/0001493152-26-028615-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315226028615/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T12:06:48.125518+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}